HYPERION DEFI, INC. Convertible Notes Payable, Current
HYPERION DEFI, INC. (HYPD) had Convertible Notes Payable, Current of $9.28 million as of 2025-03-31, per its 10-Q filed 2025-05-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-03-30
- 2025-03-31: Convertible Notes Payable, Current $9.28M.
- 2024-12-31: Convertible Notes Payable, Current $4.74M.
- 2024-09-30: Convertible Notes Payable, Current $3.26M.
- 2024-06-30: Convertible Notes Payable, Current $815.22K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2025-03-31 | $9.28M 10-Q · filed 2025-05-19 |
| 2024-12-31 | $4.74M 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.26M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $815.22K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $709.85K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $174.45K 10-K · filed 2024-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |